Document is current
Any future updates will be listed below
-
Authors
Mehra, Sonal https://orcid.org/0000-0002-4335-6176
Usdadiya, Jignesh B. https://orcid.org/0000-0001-7733-3223
Jain, Vikramraj K. https://orcid.org/0000-0002-6011-3731
Misra, Durga Prasanna https://orcid.org/0000-0002-5035-7396
Negi, Vir Singh https://orcid.org/0000-0003-1518-6031
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02645565 at ClinicalTrials.govDocuments that mention this clinical trial
Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study
https://doi.org/10.1007/s00296-018-3995-3
-
Funding
Funding for this research was provided by:
Indian Rheumatology Association
- License Information
-
More Information
Article History
Received: 30 December 2017
Accepted: 7 February 2018
First Online: 15 February 2018
Compliance with ethical standards
:
: Sonal Mehra declares that she has no conflict of interest. Jignesh Usdadiya declares that he has no conflict of interest. Vikramraj Jain declares that he has no conflict of interest. Durga Prasanna Misra declares that he has no conflict of interest. Vir Singh Negi declares that he has no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Jawaharlal Institute of post graduate medical education and research committee Number : JIP/IEC/SC/2013/5/435 dated 4.3.2014 and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards
: Informed consent was obtained from all individual participants included in the study.
